Trial NCT02781506

View at ClinicalTrials.gov 
Org. Study IDs: STU 122015-052

Last trial update was posted on 2022-08-08

MeSH Interventions

Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Metastatic Clear Cell Renal Cell Carcinoma

Stopping Reasons

Since the treatment landscape for metastatic kidney cancer changed, patients were not becoming eligible for this trial and therefore, the trial was terminated.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID